An increased diagnostic sensitivity of truncated GAD65 autoantibodies in type 1 diabetes may be related to HLA-DQ8

Diabetes

Volumn 66, Issue 3, 2017, Pages 735-740

  Wester, Axel ^a   Skärstrand, Hanna ^a   Lind, Alexander ^a   Ramelius, Anita ^a   Carlsson, Annelie ^a   Cedervall, Elisabeth ^b   Jönsson, Björn ^c   Ivarsson, Sten A ^a   Larsson, Helena Elding ^a   Larsson, Karin ^d   Lindberg, Bengt ^a   Neiderud, Jan ^e   Fex, Malin ^a   Törn, Carina ^a   Lernmark, Ake ^a  

^a LUND UNIVERSITY   (Sweden)

^b Angelholm Hospital   (Sweden)

^c Ystad Hospital   (Sweden)

^d CENTRAL HOSPITAL   (Sweden)

^e HELSINGBORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENTARY DNA; FULL LENGTH GLUTAMATE DECARBOXYLASE 65 AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; IODINE 125; TRUNCATED GLUTAMATE DECARBOXYLASE 65 AUTOANTIBODY; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8 AUTOANTIBODY; GAD65 (96-585); GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; HLA DQ ANTIGEN; PEPTIDE FRAGMENT;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; CASE CONTROL STUDY; GENETICS; HAPLOTYPE; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HAPLOTYPES; HLA-DQ ANTIGENS; HUMANS; INFANT; MALE; PEPTIDE FRAGMENTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 85016457125     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0891     Document Type: Article

References (23)

1. Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem 2011; 57:168-175
2. Andersson C, Larsson K, Vaziri-Sani F, et al. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity 2011;44:394-405
3. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-1197
4. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003;362:1275-1281
5. Graham J, Hagopian WA, Kockum I, et al.; Diabetes Incidence in Sweden Study Group; Swedish Childhood Diabetes Study Group. Genetic effects on agedependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002;51:1346-1355
6. Delli AJ, Vaziri-Sani F, Lindblad B, et al.; Better Diabetes Diagnosis Study Group. Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study. Diabetes 2012;61:2556-2564
7. Williams AJ, Lampasona V, Schlosser M, et al.; Participating Laboratories. Detection of antibodies directed to the N-Terminal region of GAD is dependent on assay format and contributes to differences in the specificity of GAD autoantibody assays for type 1 diabetes. Diabetes 2015;64:3239-3246
8. Williams AJ, Lampasona V, Wyatt R, et al. Reactivity to N-Terminally truncated GAD65(96-585) identifies GAD autoantibodies that are more closely associated with diabetes progression in relatives of patients with type 1 diabetes. Diabetes 2015;64:3247-3252
9. Giannopoulou EZ, Winkler C, Chmiel R, et al. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia 2015;58:2317-2323
10. Andersson C, Kolmodin M, Ivarsson SA, et al.; Better Diabetes Diagnosis Study Group. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies. Pediatr Diabetes 2014;15:336-344
11. Skärstrand H, Vaziri-Sani F, Delli AJ, et al.; Skane study group. Neuropeptide Y is a minor autoantigen in newly diagnosed type 1 diabetes patients. Pediatr Diabetes 2015;16:621-628
12. Nilsson AL, Vaziri-Sani F, Andersson C, et al. Relationship between Ljungan virus antibodies, HLA-DQ8, and insulin autoantibodies in newly diagnosed type 1 diabetes children. Viral Immunol 2013;26:207-215
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27(Suppl. 1):S5-S10
14. Grubin CE, Daniels T, Toivola B, et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994;37:344-350
15. Mire-Sluis AR, Gaines Das R, Lernmark A. The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia 2000;43: 1282-1292
16. Kiviniemi M, Hermann R, Nurmi J, et al.; TEDDY Study Group. A highthroughput population screening system for the estimation of genetic risk for type 1 diabetes: An application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther 2007;9:460-472
17. Larsson HE, Lynch K, Lernmark B, Hansson G, Lernmark A, Ivarsson SA. Relationship between increased relative birthweight and infections during pregnancy in children with a high-risk diabetes HLA genotype. Diabetologia 2007;50: 1161-1169
18. Hagopian WA, Erlich H, Lernmark A, et al.; TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 2011; 12:733-743
19. Schlosser M, Banga JP, Madec AM, et al. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes. Diabetologia 2005;48:922-930
20. Hampe CS, Hall TR, Agren A, Rolandsson O. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes. Clin Exp Immunol 2007; 148:72-78
21. Van Loghem E, Frangione B, Recht B, Franklin EC. Staphylococcal protein A and human IgG subclasses and allotypes. Scand J Immunol 1982;15:275-278
22. Hillman M, Törn C, Landin-Olsson M; DISS study group. The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adultonset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset. Clin Exp Immunol 2009;157:255-260
23. Krischer JP, Lynch KF, Schatz DA, et al.; TEDDY Study Group. The 6 year incidence of diabetes-Associated autoantibodies in genetically at-risk children: The TEDDY study. Diabetologia 2015;58:980-987